Results 181 to 190 of about 5,138,607 (284)

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis [PDF]

, 2012
Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman, Kurt Lippuner, José Zanchetta, Bente Langdahl, René Rizzoli, Stanley Lipschitz, Hans Peter Dimai, Richard Witvrouw, Erik Fink Eriksen, Kim Brixen, Luis Augusto Tavares Russo, Frank Claessens, P. Papanastasiou, Oscar Antúnez, Guoqin Su, Christina Bucci‐Rechtweg, Josef Hruska, Elodie Incera, Dirk Vanderschueren, Eric Orwoll   +21 more
openalex   +1 more source

Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer. [PDF]

Breast
Zecca E, Zambelli L, Tinè G, Bracchi P, Miceli R, Pigni A, Lo Dico S, Ricchini F, Mariani G, Massa G, Caraceni A.   +10 more
europepmc   +1 more source

Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer [PDF]

, 2010
Bülent Karabulut, Burçak Karaca, Umut Varol, Ugur Muslu, Burcu Çakar, Harika Atmaca, Aslı Kısım, Selim Uzunoğlu, Rüçhan Uslu   +8 more
openalex   +1 more source

Zoledronic Acid in the Treatment of Primary Knee Osteoarthritis: A Randomized Clinical Trial. [PDF]

Cureus
Ealahi T, Azad MAK, Islam MN, Hassan MM, Ferdous N, Rashid FB, Tazbir A.   +6 more
europepmc   +1 more source

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial [PDF]

, 2010
Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Kim Cocks, Sue Bell, Alex J. Szubert, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, A. John Ashcroft, Fiona Ross, Jenny Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham Jackson, J. Anthony Child   +17 more
openalex   +1 more source

Modulatory efficacy of bone metabolism and safety of denosumab versus zoledronic acid in the treatment of bone and joint osteoporosis in elderly men. [PDF]

Front Pharmacol
He J, Mao Y, Gong W, Zhu H, Xiang P, Wang S, Dai X.   +6 more
europepmc   +1 more source

Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

, 2009
Marta Coscia, Elena Quaglino, Manuela Iezzi, Claudia Curcio, Francesca Pantaleoni, Chiara Riganti, Ingunn Holen, Hannu Mönkkönen, Mario Boccadoro, Guido Forni, Piero Musiani, Amalia Bosìa, Federica Cavallo, Massimo Massaia   +13 more
openalex   +2 more sources

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta. [PDF]

Calcif Tissue Int
Hald JD, Weir C, Keerie C, Dewar L, MacLean M, Milne L, Keen R, Walsh J, Poole K, Langdahl B, Lindsay JR, Ghouri N, Hollick RJ, Aspray T, Crowley RK, Cohen-Solal M, Hassan-Smith Z, Tuck S, Curtis E, Harvey N, Eekhoff EMW, Feenstra J, Hampson G, Stone M, Turton J, Patel P, Siddiqi M, Munro R, Roy M, Paskins Z, Narayanan D, Malcolm E, Javaid MK, Osborne P, Tang JCY, Lam W, Moore D, Black HA, Duckworth AD, Makaram N, Guo T, Stenhouse G, Ralston SH.   +42 more
europepmc   +1 more source

Bisphosphonate Use in Acute Spinal Cord Injury: A Focused Systematic Review on Zoledronic Acid. [PDF]

Cureus
Mun S, Chalasani R, Van de Vel G, Shukla PS, Zia SUD, Mohammed L.   +5 more
europepmc   +1 more source

Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients

, 2011
Seung Ah Lee, Seung Hyun Hwang, Sung Gwe Ahn, Hak Min Lee, Joon Jeong, Hy-De Lee   +5 more
openalex   +2 more sources